RYAN HOOVER: Open Payments
NPI 1548511207 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 56 payments from 20 companies in 2025. Trend: 2023 $714 · 2024 $912 · 2025 $1,156
Food & beverage: $1,057Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $258 |
| UCB, Inc. | 12 | $149 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Incyte Corporation | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Medtronic, Inc. | 2 | $61 |
| Endo USA, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $44 |
Products named: DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, OPZELURA, Xtandi, INTERSTIM, AVEED.
Industry payments across NC — which companies pay providers there.
